New incident report
Incident Report Number: 2020-4264
Registrant Reference Number: 2020-US-010779
Registrant Name (Full Legal Name no abbreviations): Wellmark International
Address: 100 Stone Road West, Suite 111
City: Guelph
Prov / State: Ontario
Country: Canada
Postal Code: N1G5L3
Domestic Animal
Country: UNITED STATES
Prov / State: WASHINGTON
PMRA Registration No. PMRA Submission No. EPA Registration No. 2724-829-89459
Product Name: Adams Pentagon Flea And Tick Spot On For Dogs
Liquid
Yes
Unknown
Site: Animal / Usage sur un animal domestique
No
Animal's Owner
Cat / Chat
Unknown
1
Unknown
Unknown
Unknown
Skin
>8 hrs <= 24 hrs / >8 h <= 24 h
>8 hrs <=24 hrs / > 8 h < = 24 h
System
Persisted until death
No
No
Died
Treatment / Traitement
(eg. description of the frequency and severity of the symptoms
On the afternoon or evening of 5-May-2020 the product was applied to the cat. This cat died at an unspecified time 6-May-2020. No further information is available.
Death
Assessment: Etofenprox, a non-ester pyrethroid, and the other ingredients present in this product are considered to have a good safety margin in cats. As with application of any topical product individual sensitivities may occur. This product is not labelled for use on cats. However severe adverse effects including death are not expected, even with off label use. Other causes should be considered including exposure to a permethrin containing canine flea and tick product, other toxic exposure, underlying disease, and infection. Necropsy may have provided additional information but was not pursued by the animal owner. The information contained in this report is based on self-reported statements provided to the registrant during telephone Interview(s). These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and cannot form the basis for a determination of whether the reported clinical effects are causally related to exposure to the product identified in the telephone interviews. The information contained in this report is based on self-reported statements provided to the registrant during telephone Interview(s). These self-reported descriptions of an incident have not been independently verified to be factually correct or complete descriptions of the incident. For that reason, information contained in this report does not and cannot form the basis for a determination of whether the reported clinical effects are causally related to exposure to the product identified in the telephone interviews.